“Obesity Can Kill”: Ozempic’s Controversial Pharmaceutical Campaign Sparks Controversy

El Pais

Lean Left

Factuality

Ownership

“This content is extremely delicate and can hurt the sensitivity”, warns a campaign by the pharmaceutical company Novo Nordisk that soaks up marquees in Madrid. Next, in capital letters, the poster promoted by the company manufacturer of the famous antiobesity drug Ozempic, emphasizes that obesity is “a disease” and that “it can kill”: “It is a health problem, not aesthetics. And it continues to expand while we discuss how to talk about it”, con…